Astellas Announces Key Leadership Appointments in Ethics and Compliance and US Legal Organizations

Mark Wanda will join the Ethics and Compliance organization in the role of executive director, anti-bribery and anti-corruption, where he will oversee global anti-bribery and anti-corruption compliance programs for Astellas. Wanda joined Astellas in 2013 as deputy general counsel, and most recently served as head of the Astellas US legal regulatory team. In his new role, Wanda will report to Catherine Wertjes, senior vice president, Ethics and Compliance.

"Working with the highest sense of integrity and ethics is a cornerstone of our business," said Wertjes. "We have the utmost confidence that Mark's skills and experience will enable us to continue to further Astellas' standard for global compliance." 

Nahrin Marino has been promoted to deputy general counsel, and will succeed Wanda as head of Astellas US legal regulatory. Marino will continue to serve as director of investigations. Marino joined Astellas in 2010 as senior corporate counsel, specializing in regulatory law.  She most recently served as associate general counsel, focused on regulatory, life cycle management, drug quality and manufacturing. In her new role, Marino will report to Catherine Levitt, vice president, Legal.

Matt Silversten has also been promoted to deputy general counsel, and is the new head of the Astellas US Legal department's litigation and risk management team. Silversten joined Astellas in 2011 as senior counsel litigation. He most recently served as associate general counsel, where he was responsible for litigation and dispute resolution. In his new role, Silversten will also report to Levitt.

"Nahrin and Matt have been instrumental to the growth of our Legal department in the Americas region over the past five years," said Levitt. "Their collective experience enhances Astellas' response to diverse legal issues."

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.

Photo - http://photos.prnewswire.com/prnh/20160425/359687
Photo - http://photos.prnewswire.com/prnh/20160425/359688
Photo - http://photos.prnewswire.com/prnh/20160425/359689
Logo - http://photos.prnewswire.com/prnh/20140416/84970

SOURCE Astellas

Related Links

http://www.astellas.us